Angela M. Lam

3.5k total citations · 1 hit paper
61 papers, 2.7k citations indexed

About

Angela M. Lam is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Angela M. Lam has authored 61 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 42 papers in Hepatology and 24 papers in Infectious Diseases. Recurrent topics in Angela M. Lam's work include Hepatitis C virus research (42 papers), Hepatitis B Virus Studies (40 papers) and HIV/AIDS drug development and treatment (20 papers). Angela M. Lam is often cited by papers focused on Hepatitis C virus research (42 papers), Hepatitis B Virus Studies (40 papers) and HIV/AIDS drug development and treatment (20 papers). Angela M. Lam collaborates with scholars based in United States, Canada and Belgium. Angela M. Lam's co-authors include David N. Frick, Christine Espiritu, Phillip A. Furman, Michaël Otto, Shalini Bansal, Holly M. Micolochick Steuer, Michael J. Sofia, Congrong Niu, Meg Keilman and Pieter R. Cullis and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Angela M. Lam

60 papers receiving 2.6k citations

Hit Papers

Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methylurid... 2010 2026 2015 2020 2010 100 200 300 400

Peers

Angela M. Lam
Congrong Niu United States
Nanhua Yao United States
Kai Lin United States
Christine Espiritu United States
Sophie Le Pogam United States
Klaus Klumpp United States
D R Averett United States
Brent E. Korba United States
Jin-Hua Sun United States
Congrong Niu United States
Angela M. Lam
Citations per year, relative to Angela M. Lam Angela M. Lam (= 1×) peers Congrong Niu

Countries citing papers authored by Angela M. Lam

Since Specialization
Citations

This map shows the geographic impact of Angela M. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela M. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela M. Lam more than expected).

Fields of papers citing papers by Angela M. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela M. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela M. Lam. The network helps show where Angela M. Lam may publish in the future.

Co-authorship network of co-authors of Angela M. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Angela M. Lam. A scholar is included among the top collaborators of Angela M. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela M. Lam. Angela M. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mesaros, Eugen F., Andrew G. Cole, Steven G. Kultgen, et al.. (2024). Conformationally Constrained Isoquinolinones as Orally Efficacious Hepatitis B Capsid Assembly Modulators. ACS Medicinal Chemistry Letters. 15(9). 1627–1634. 2 indexed citations
2.
Lam, Angela M., Muhammad Sheraz, Fei Liu, et al.. (2024). Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161. Viruses. 16(3). 323–323. 5 indexed citations
3.
Thi, Emily P., Xin Ye, Nicholas M. Snead, et al.. (2024). Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic. ACS Infectious Diseases. 10(10). 3640–3649. 6 indexed citations
4.
Stoops, Bart, P.L. Shaffer, Angela M. Lam, et al.. (2023). Di-fluoro azepane HBV capsid assembly modulators. Bioorganic & Medicinal Chemistry Letters. 92. 129350–129350. 1 indexed citations
5.
Kuduk, Scott D., Bart Stoops, Richard Alexander, et al.. (2021). Identification of a new class of HBV capsid assembly modulator. Bioorganic & Medicinal Chemistry Letters. 39. 127848–127848. 11 indexed citations
6.
Kuduk, Scott D., Angela M. Lam, Christine Espiritu, et al.. (2019). SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulators. Bioorganic & Medicinal Chemistry Letters. 29(16). 2405–2409. 12 indexed citations
7.
Klumpp, Klaus, Takashi Shimada, Lena Allweiss, et al.. (2017). Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection. Gastroenterology. 154(3). 652–662.e8. 78 indexed citations
8.
Fyfe, Janet, Simon J. Foster, John H. Jardine, et al.. (2013). Detection and identification of mycobacteria in fixed stained smears and formalin‐fixed paraffin‐embedded tissues using PCR. Journal of Small Animal Practice. 54(12). 638–646. 14 indexed citations
9.
Du, Jinfa, Donghui Bao, Ying Jiang, et al.. (2012). β-d-2′-α-F-2′-β-C-Methyl-6-O-substituted 3′,5′-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: A structure–activity relationship study. Bioorganic & Medicinal Chemistry Letters. 22(18). 5924–5929. 13 indexed citations
10.
Furman, Phillip A., Eisuke Murakami, Congrong Niu, et al.. (2011). Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661. Antiviral Research. 91(2). 120–132. 36 indexed citations
11.
Frick, David N., et al.. (2009). A Method to Simultaneously Monitor Hepatitis C Virus NS3 Helicase and Protease Activities. Methods in molecular biology. 587. 223–233. 14 indexed citations
12.
Heck, Julie A., et al.. (2008). Effects of Mutagenic and Chain-Terminating Nucleotide Analogs on Enzymes Isolated from Hepatitis C Virus Strains of Various Genotypes. Antimicrobial Agents and Chemotherapy. 52(6). 1901–1911. 24 indexed citations
13.
Frick, David N. & Angela M. Lam. (2006). Understanding Helicases as a Means of Virus Control. Current Pharmaceutical Design. 12(11). 1315–1338. 91 indexed citations
14.
Lam, Angela M., et al.. (2005). Calcium enhances the transfection potency of stabilized plasmid–lipid particles. Analytical Biochemistry. 341(1). 156–164. 19 indexed citations
15.
Lam, Angela M.. (2004). Enhanced nucleic acid binding to ATP-bound hepatitis C virus NS3 helicase at low pH activates RNA unwinding. Nucleic Acids Research. 32(13). 4060–4070. 31 indexed citations
16.
Frick, David N., et al.. (2004). The Nonstructural Protein 3 Protease/Helicase Requires an Intact Protease Domain to Unwind Duplex RNA Efficiently. Journal of Biological Chemistry. 279(2). 1269–1280. 92 indexed citations
17.
Lam, Angela M., David Keeney, & David N. Frick. (2003). Two Novel Conserved Motifs in the Hepatitis C Virus NS3 Protein Critical for Helicase Action. Journal of Biological Chemistry. 278(45). 44514–44524. 56 indexed citations
18.
Palmer, Lorne, Tao Chen, Angela M. Lam, et al.. (2003). Transfection properties of stabilized plasmid–lipid particles containing cationic PEG lipids. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1611(1-2). 204–216. 39 indexed citations
19.
Lam, Angela M. & Pieter R. Cullis. (2000). Calcium enhances the transfection potency of plasmid DNA–cationic liposome complexes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1463(2). 279–290. 61 indexed citations
20.
Lam, Angela M., et al.. (1999). Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1419(2). 137–150. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026